As Nature Neuroscience celebrates its 25th anniversary, we are having conversations with both established leaders in the field and those earlier in their careers to discuss how the field has evolved and where it is heading. This month we are talking to Bill Martin, Global Therapeutic Area Head, Neuroscience at Johnson & Johnson Innovative Medicine. We discussed the challenges and opportunities ahead for the development of treatments for psychiatric disease.
This is a preview of subscription content, log in via an institution to check access.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wiseman, S. In conversation with Bill Martin. Nat Neurosci 27, 211–215 (2024). https://doi.org/10.1038/s41593-023-01544-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41593-023-01544-9
- Springer Nature America, Inc.